Clinical Research Directory
Browse clinical research sites, groups, and studies.
Guanfacine for Alcohol Use Disorder (AUD)
Sponsor: Indiana University
Summary
The investigators assess whether guanfacine extended release (GXR; 3mg/d) compared with placebo (PBO) will attenuate drinking and drinking-related factors in N=200 men and women with Alcohol Use Disorder (AUD) across 12-weeks.
Official title: Guanfacine for Alcohol Use Disorder (AUD): a Telehealth Approach
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2025-09-01
Completion Date
2029-09-07
Last Updated
2025-09-18
Healthy Volunteers
No
Conditions
Interventions
Guanfacine Extended Release (XR)
3mg tablet once daily
Placebo
placebo tablet once daily
Locations (2)
The Stark Neuroscience Building (Goodman Hall)
Indianapolis, Indiana, United States
Rutgers School of Health Professionals
Newark, New Jersey, United States